Nanomechanical resonators have shown potential application for mass sensing and have been used to detect a variety of biomolecules. In this study, a dynamic resonance-based technique was used to detect prion proteins (PrP), which in conformationally altered forms are known to cause neurodegenerative diseases in animals as well as humans. Antibodies and nanoparticles were used as mass labels to increase the mass shift and thus amplify the frequency shift signal used in PrP detection. A sandwich assay was used to immobilize PrP between two monoclonal antibodies, one of which was conjugated to the resonator's surface while the other was either used alone or linked to the nanoparticles as a mass label. Without additional mass labeling, PrP was not detected at concentrations below 20 µg/mL. In the presence of secondary antibodies the analytical sensitivity was improved to 2 µg/mL. With the use of functionalized nanoparticles, the sensitivity improved an additional 3 orders of magnitude to 2 ng/mL.Prion proteins (PrP) are transmissible infectious particles, devoid of nucleic acid, that cause fatal neurodegenerative diseases known as bovine spongiform encephalopathy (BSE) in bovine, scrapie (SC) in sheep, and Creutzfeldt-Jakob disease (CJD) in humans. 1 These diseases are caused by genetic, infectious, or sporadic disorders where host-encoded, noninfectious cellular prion proteins (PrP c ) are converted into a conformationally altered, infectious forms designated as PrP sc , PrP CJD , and PrP BSE . 2,3 PrP c is present in abundance in most tissues of the central nervous system. However, posttranslational processes convert PrP c into PrP sc , which leads to altered physiochemical and biochemical properties such as aggregation, insolubility, protease digestion resistance, and a -sheet-rich secondary structure.One such altered property of PrP sc , namely, protease digestion resistance, forms the basis of several diagnostic biochemical tests.To differentiate between PrP c and PrP sc , the sample is pretreated with protease K. Since PrP sc is digestion resistant and PrP c is easily digested by protease K, pretreatment results in a sample that is rich in PrP sc as compared to PrP c . 4,5 Because neither the sensitivity of PrP c nor the resistance of PrP sc to digestion is absolute, the "protease sensitivity assay" cannot definitively measure the presence or absence of PrP.Current prion detection methods employ post mortem analysis after suspicious animals manifest one or more symptoms of the disease. These post mortem tests include gel electrophoresis and western blot, direct-binding and sandwich ELISA, and conformational-dependent immunoassay. [4][5][6] To improve food safety it would be beneficial to screen all the animals for prion disease using ante mortem testing, regardless of the presence of symptoms. Because ante mortem tests could be performed on presymptomatic animals, they would therefore be required to detect extremely small amounts of PrP circulating in blood samples and would have to differentiate PrP c and PP ...